ARC Clinical Trial Research Leads to Better Patient Care

Associated Retina Consultants is committed to the highest level of patient care and saving the vision of their patients who suffer from significant retinal disease. There are times, however, when current treatment options, retina surgeries, or other available retinal therapies are not enough to treat some patients who suffer from advanced forms of varying retinal conditions. Because ARC is committed to finding new treatment options for these patients, the retinal physicians at ARC are highly involved in a wide range of national clinical trial research studies.

Clinical trials are essential to developing new treatments, care, and prevention of serious retinal diseases.  The ARC retinal physicians continually participate in clinical trial investigator meetings around the United States as each new trial begins and develops. Most recently, Dr. Matthew Welch joined retinal physicians from across the country in Dallas, Texas to discuss the early findings and the ongoing study of a completely new therapy under investigation.

Reflecting on this recent trip, Dr. Welch commented on the experience, “It’s always enriching to gather with other leading retinal physicians from different regions of the country. So much can be learned from each other, as our experiences with these diseases can be so varied because of different patient populations. I always return from these meetings with a renewed sense of commitment to research as we seek new therapies to elevate our ability to maintain and save vision for our patients to the next level.”

ARC is currently offering patients the opportunity to enroll in clinical trials related to Dry Macular Degeneration, Wet Macular Degeneration, Diabetic Retinopathy, and Diabetic Macular Edema. When meeting with your retina specialist, keep these studies in mind as possible options. To learn more information about these studies, please contact us at 602-242-4928.